Careers  |  Sign In  |  Register

Latest in Pharmacists

The U.S. Food and Drug Administration has approved the antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 diagnosed with schizophrenia. References and Resources U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for Adolescent Patients with Schizophrenia Click Here...

Risk of myocardial ischemia

Avandia’s New Warning

This update highlights changes to the prescribing information for Avandia including a new boxed warning about the potential increased risk of myocardial ischemia. References and Resources FDA adds a new warning about the risk of myocardial ischemia to the boxed warning for Avandia. Click Here to...

Promising results in a phase II study

Avastin and Glioblastoma Multiforme

Avastin shows promise in a phase II study in glioblastoma multiforme. References and Resources Avastin Clinical Trial Information Click Here to view information. Vredenburgh J, Desjardins A, Herndon J, et al. Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme. Journal of Clinical...